{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:54:37Z","timestamp":1777888477547,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RNN"],"published-print":{"date-parts":[[2015,10,5]]},"DOI":"10.3233\/rnn-150549","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T12:15:07Z","timestamp":1444133707000},"page":"777-784","source":"Crossref","is-referenced-by-count":7,"title":["Uridine protects against hypoxic-ischemic brain injury by reducing histone deacetylase activity in neonatal rats"],"prefix":"10.1177","volume":"33","author":[{"given":"Turkan","family":"Koyuncuoglu","sequence":"first","affiliation":[{"name":"Uludag University Medical School Department of Physiology, Bursa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Turkyilmaz","sequence":"additional","affiliation":[{"name":"Uludag University Medical School Department of Pharmacology, Bursa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulent","family":"Goren","sequence":"additional","affiliation":[{"name":"Uludag University Medical School Department of Physiology, Bursa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merih","family":"Cetinkaya","sequence":"additional","affiliation":[{"name":"Kanuni Sultan Suleyman Training and Research Hospital, Department of Pediatrics, Division of Neonatology, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Cansev","sequence":"additional","affiliation":[{"name":"Uludag University Medical School Department of Pharmacology, Bursa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulin","family":"Alkan","sequence":"additional","affiliation":[{"name":"Uludag University Medical School Department of Physiology, Bursa, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/RNN-150549_ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: Update on the PY G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.3233\/RNN-150549_ref2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1203\/00006450-200111000-00010","article-title":"Combination effect of systemic hypothermia and caspase inhibitor administration against hypoxic\u2013 ischemic brain damage in neonatal rats","volume":"50","author":"Adachi","year":"2001","journal-title":"Pediatr Res"},{"key":"10.3233\/RNN-150549_ref3","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1101\/gad.436407","article-title":"HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates","volume":"21","author":"Boyault","year":"2007","journal-title":"Genes Dev"},{"key":"10.3233\/RNN-150549_ref4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.brainresrev.2006.05.001","article-title":"Uridine and cytidine in the brain: Their transport and utilization","volume":"52","author":"Cansev","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.3233\/RNN-150549_ref5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/187152407783220814","article-title":"Involvement of uridine-nucleotide-stimulated PY receptors in neuronal growth and function","volume":"7","author":"Cansev","year":"2007","journal-title":"Cent Nerv Sys Agents Med Chem"},{"key":"10.3233\/RNN-150549_ref6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neulet.2013.02.035","article-title":"Neuroprotective effects of uridine in a rat model of neonatal hypoxic-ischemic encephalopathy","volume":"542","author":"Cansev","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.3233\/RNN-150549_ref7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuropharm.2014.12.019","article-title":"Evidence for the existence of pyrimidinergic transmission in rat brain","volume":"91","author":"Cansev","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.3233\/RNN-150549_ref8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuroscience.2007.06.016","article-title":"Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils","volume":"148","author":"Cansev","year":"2007","journal-title":"Neuroscience"},{"key":"10.3233\/RNN-150549_ref9","first-page":"10","article-title":"Liposomal-formulated curcumin [Lipocurctrademark] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson\u2019s disease: Implications for epigenetics-based nanotechnology-driven drug platform","volume":"7","author":"Chiu","year":"2013","journal-title":"J Complement Integr Med"},{"key":"10.3233\/RNN-150549_ref10","doi-asserted-by":"crossref","first-page":"e11383","DOI":"10.1371\/journal.pone.0011383","article-title":"Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats","volume":"5","author":"Dash","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/RNN-150549_ref11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2010.01.011","article-title":"HDAC inhibitors and neurodegeneration: At the edge between protection and damage","volume":"62","author":"Dietz","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.3233\/RNN-150549_ref12","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.3233\/RNN-150549_ref13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1742-2094-9-70","article-title":"Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury","volume":"9","author":"Fleiss","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.3233\/RNN-150549_ref14","doi-asserted-by":"crossref","first-page":"25748","DOI":"10.1074\/jbc.M111871200","article-title":"Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/RNN-150549_ref15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: Implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.3233\/RNN-150549_ref16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/RNN-150549_ref17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1124\/jpet.107.120188","article-title":"Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: Multiple mechanisms of action","volume":"321","author":"Kim","year":"2007","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.3233\/RNN-150549_ref18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","article-title":"Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy","volume":"86","author":"Kurinczuk","year":"2010","journal-title":"Early Hum Dev"},{"key":"10.3233\/RNN-150549_ref19","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1073\/pnas.0706487104","article-title":"Unraveling the hidden catalytic activity of vertebrate class Ila histone deacetylases","volume":"104","author":"Lahm","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.3233\/RNN-150549_ref20","doi-asserted-by":"crossref","first-page":"609813","DOI":"10.1155\/2011\/609813","article-title":"Perinatal hypoxic-ischemic encephalopathy","volume":"2011","author":"Lai","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.3233\/RNN-150549_ref21","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1523\/JNEUROSCI.20-21-07994.2000","article-title":"Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat","volume":"20","author":"Martin","year":"2000","journal-title":"J Neurosci"},{"key":"10.3233\/RNN-150549_ref22","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1523\/JNEUROSCI.20-21-07994.2000","article-title":"Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat","volume":"20","author":"Nakajima","year":"2000","journal-title":"J Neurosci"},{"key":"10.3233\/RNN-150549_ref23","first-page":"435","article-title":"Neuroprotective effects of melatonin administered alone or in combination with topiramate in neonatal hypoxic-ischemic rat model","volume":"30","author":"Ozyener","year":"2012","journal-title":"Restor Neurol Neurosci"},{"issue":"Suppl 1","key":"10.3233\/RNN-150549_ref24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/14767058.2012.663168","article-title":"New pharmacologic and therapeutic approaches for hypoxic-ischemic encephalopathy in the newborn","volume":"25","author":"Perrone","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.3233\/RNN-150549_ref25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02406.x","article-title":"Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: Potential roles of histone deacetylase inhibition and heat shock protein induction","volume":"89","author":"Ren","year":"2004","journal-title":"J Neurochem"},{"key":"10.3233\/RNN-150549_ref26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2007.08.089","article-title":"Oral supplementation with docosahexaenoic acid and uridine-5\u2032-monophosphate increases dendritic spine density in adult gerbil hippocampus","volume":"1182","author":"Sakamoto","year":"2007","journal-title":"Brain Res"},{"key":"10.3233\/RNN-150549_ref27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02479423","article-title":"Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl\u20132\u2013related protein Bad","volume":"18","author":"Sawa","year":"2001","journal-title":"Brain Tumor Pathol"},{"key":"10.3233\/RNN-150549_ref28","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1096\/fj.09-134700","article-title":"Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury","volume":"23","author":"Shein","year":"2009","journal-title":"FASEB J"},{"key":"10.3233\/RNN-150549_ref29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.nbd.2007.02.006","article-title":"Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation","volume":"26","author":"Sinn","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.3233\/RNN-150549_ref30","first-page":"955","article-title":"The hypoxic ischemic encephalopathy model of perinatal ischemia","volume":"21","author":"Taniguchi","year":"2008","journal-title":"J Vis Exp"},{"key":"10.3233\/RNN-150549_ref31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","article-title":"Histone deacetylases: Unique players in shaping the epigenetic histone code","volume":"983","author":"Thiagalingam","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.3233\/RNN-150549_ref32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10571-006-9004-5","article-title":"Cytidine and uridine increase striatal CDP-choline levels without decreasing acetylcholine synthesis or release","volume":"26","author":"Ulus","year":"2006","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/RNN-150549_ref33","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1523\/JNEUROSCI.6186-08.2009","article-title":"Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms","volume":"29","author":"Uo","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/RNN-150549_ref34","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1242\/jeb.01064","article-title":"Hypoxia-ischemia in the immature brain","volume":"207","author":"Vannucci","year":"2004","journal-title":"J Exp Biol"},{"key":"10.3233\/RNN-150549_ref35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1749-6632.1997.tb48634.x","article-title":"A model of perinatal hypoxic\u2013 ischemic brain damage","volume":"835","author":"Vannucci","year":"1997","journal-title":"Ann NY Acad Sci"},{"key":"10.3233\/RNN-150549_ref36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000085978","article-title":"Perinatal hypoxic\u2013 ischemic brain damage: Evolution of an animal model","volume":"27","author":"Vannucci","year":"2005","journal-title":"Dev Neurosci"},{"key":"10.3233\/RNN-150549_ref37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.nepig.2014.10.002","article-title":"Histone deacetylases (HDACs) and brain function","volume":"1","author":"Volmar","year":"2014","journal-title":"Neuroepigenetics"},{"key":"10.3233\/RNN-150549_ref39","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/jcb.21746","article-title":"Histone deacetylases as transducers and targets of nuclear signaling","volume":"104","author":"Walkinshaw","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.3233\/RNN-150549_ref40","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.freeradbiomed.2011.12.006","article-title":"Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage","volume":"52","author":"Wang","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/RNN-150549_ref41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0006-2952(00)00436-6","article-title":"Effect of oral CDP-choline on plasma choline and uridine levels in humans","volume":"60","author":"Wurtman","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/RNN-150549_ref42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2006.03.019","article-title":"Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally","volume":"1088","author":"Wurtman","year":"2006","journal-title":"Brain Res"}],"container-title":["Restorative Neurology and Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/RNN-150549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:46:41Z","timestamp":1777610801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medra.org\/servlet\/aliasResolver?alias=iospress&doi=10.3233\/RNN-150549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,5]]},"references-count":41,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3233\/rnn-150549","relation":{},"ISSN":["0922-6028","1878-3627"],"issn-type":[{"value":"0922-6028","type":"print"},{"value":"1878-3627","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,5]]}}}